Omeros Corporation (NASDAQ: OMER) today announced a revised date for its conference call to discuss the recent FDA approval of YARTEMLEA ® (narsoplimab-wuug), the first and only therapy indicated for ...
Orrstown Financial Services, Inc. will announce Q1 2025 earnings on April 22 and host a conference call on April 23. Orrstown Financial Services, Inc. announced that it will release its first quarter ...